Mengmeng (Margaret) Du, ScD

Assistant Attending Epidemiologist

Share
Print
Share
Print
Mengmeng (Margaret) Du, Assistant Attending Epidemiologist

Office Phone

646-888-8123

Education

Harvard University

Dr. Du studies inherited and modifiable factors in cancer—particularly colorectal, endometrial, and pancreatic cancers. She works with international research teams to understand tumor biology and identify individuals who could most benefit from risk-reducing lifestyle modifications, interventions, or early detection tools. To this end, Dr. Du studies colorectal cancer genomics, risk factors, and risk modeling in Nigeria through the African Research Group in Oncology (ARGO) as well as in North American and European populations through the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO). She investigates endometrial cancer genomics and risk, including factors that drive the 2-fold higher mortality in Black patients, in the Epidemiology of Endometrial Cancer Consortium (E2C2)—for which she is principal investigator of the Data Coordinating Center. She also examines pancreatic cancer risk factors and early detection/surveillance and is principal investigator of the MSK Pancreatic Tumor Registry. Dr. Du studies telomere dynamics in various large, population-based data sources.

Dr. Du co-chairs the E2C2 Executive Committee, co-directs the MSK Quantitative Sciences Summer Undergraduate Research Experience (QSURE), serves on the Scientific Committee for the New York City Epidemiology Forum, and is an Associate Editor for the international peer-reviewed journal Cancer Causes & Control. Her work is supported by the National Cancer Institute, National Center for Advancing Translational Sciences, David M. Rubenstein Center for Pancreatic Cancer Research Cycle for Survival, Thompson Family Foundation, and internal MSK funds.

Publications

Representative Publications

  1. Sharma A, Alatise OI, O’Connell K, Ogunleye SG, Aderounmu AA, Samson ML, Wuraola F, Olasehinde O, Kingham TP, Du M. Healthcare utilisation, cancer screening and potential barriers to accessing cancer care in rural South West Nigeria: a cross-sectional study. BMJ Open. 2021;11:e040352.
  2. Jeon J, Du M, Schoen RE, Hoffmeister M, Newcomb PA, Berndt SI, Caan B, Campbell PT, Chan AT, Chang-Claude J, Giles GG, Gong J, Harrison TA, Huyghe JR, Jacobs EJ, Li L, Lin Y, Le Marchand L, Potter JD, Qu F, Bien SA, Zubair N, Macinnis RJ, Buchanan DD, Hopper JL, Cao Y, Nishihara R, Rennert G, Slattery ML, Thomas DC, Woods MO, Prentice RL, Gruber SB, Zheng Y, Brenner H, Hayes RB, White E, Peters U, Hsu L. Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors. Gastroenterology. 2018;154(8):2152-2164.e19.
  3. Du M, Auer PL (joint lead author), Jiao S, Haessler J, Altshuler D, Boerwinkle E, Carlson CS, Carty CL, Chen YI, Curtis K, Franceschini N, Hsu L, Jackson R, Lange LA, Lettre G, Monda KL; National Heart, Lung, and Blood Institute (NHLBI) Go Exome Sequencing Project; Nickerson DA, Reiner AP, Rich SS, Rosse SA, Rotter JI, Willer CJ, Wilson JG, North K, Kooperberg C, Heard-Costa N, Peters U. Whole-exome imputation of sequence variants identified two novel alleles associated with adult body height in African Americans. Hum Mol Genet. 2014;23(24):6607-15.
  4. Du M, Kraft P, Eliassen AH, Giovannucci E, Hankinson SE, De Vivo I. Physical activity and risk of endometrial cancer in the Nurses’ Health Study. Int J Cancer. 2014;134(11):2707-16.
  5. Nan H, Du M (joint lead author), De Vivo I, Manson JE, Liu S, McTiernan A, Curb JD, Lessin LS, Bonner MR, Guo Q, Qureshi AA, Hunter DJ, Han J. Shorter telomeres associate with a reduced risk of melanoma development. Cancer Res. 2011;71(21):6758-63.

View a full listing of Mengmeng (Margaret) Du’s journal articles.

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Mengmeng (Margaret) Du discloses the following relationships and financial interests:

No disclosures meeting criteria for time period


The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2020 through disclosure submission in spring 2021). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.


View all disclosures